ARAY Accuray Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ARAY

Price (delayed)

$2.19

Market cap

$217.18M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.15

Enterprise value

$344.91M

Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. The company invents unique, market-changing solutions that are designed to deliver radiation ...

Highlights
Accuray's revenue has increased by 7% YoY
Accuray's debt has decreased by 2.5% YoY
The net income has dropped by 114% since the previous quarter and by 23% year-on-year
The EPS has plunged by 114% from the previous quarter and by 15% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://www.accuray.com
Peers: HOLX ICAD SYK

Key stats

What are the main financial stats of ARAY
Market
Shares outstanding
99.17M
Market cap
$217.18M
Enterprise value
$344.91M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.46
Price to sales (P/S)
0.48
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.77
Earnings
Revenue
$447.48M
EBIT
-$10.64M
EBITDA
-$5.64M
Free cash flow
$7.67M
Per share
EPS
-$0.15
Free cash flow per share
$0.08
Book value per share
$0.49
Revenue per share
$4.58
TBVPS
$4.28
Balance sheet
Total assets
$476.35M
Total liabilities
$428.7M
Debt
$202.22M
Equity
$47.65M
Working capital
$121.86M
Liquidity
Debt to equity
4.24
Current ratio
1.58
Quick ratio
0.73
Net debt/EBITDA
-22.66
Margins
EBITDA margin
-1.3%
Gross margin
33.9%
Net margin
-3.3%
Operating margin
0%
Efficiency
Return on assets
-3%
Return on equity
-28.1%
Return on invested capital
-3.1%
Return on capital employed
-4%
Return on sales
-2.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ARAY stock price

How has the Accuray stock price performed over time
Intraday
0.46%
1 week
2.34%
1 month
-7.59%
1 year
-18.89%
YTD
-22.61%
QTD
-11.34%

Financial performance

How have Accuray's revenue and profit performed over time
Revenue
$447.48M
Gross profit
$151.79M
Operating income
$108,000
Net income
-$14.55M
Gross margin
33.9%
Net margin
-3.3%
Accuray's net margin has shrunk by 120% QoQ and by 18% YoY
The net income has dropped by 114% since the previous quarter and by 23% year-on-year
The company's operating margin has shrunk by 100% QoQ and by 100% YoY
The company's operating income has shrunk by 98% QoQ and by 95% YoY

Growth

What is Accuray's growth rate over time

Valuation

What is Accuray stock price valuation
P/E
N/A
P/B
4.46
P/S
0.48
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.77
The EPS has plunged by 114% from the previous quarter and by 15% YoY
The price to book (P/B) is 23% lower than the last 4 quarters average of 5.8 and 16% lower than the 5-year quarterly average of 5.3
ARAY's equity is down by 8% YoY and by 6% QoQ
The price to sales (P/S) is 31% lower than the 5-year quarterly average of 0.7 and 31% lower than the last 4 quarters average of 0.7
Accuray's revenue has increased by 7% YoY

Efficiency

How efficient is Accuray business performance
Accuray's ROE has plunged by 118% from the previous quarter and by 21% YoY
The company's return on assets has shrunk by 114% QoQ and by 20% YoY
The ROIC has decreased by 29% YoY
The ROS has contracted by 26% YoY

Dividends

What is ARAY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ARAY.

Financial health

How did Accuray financials performed over time
The company's total assets is 11% higher than its total liabilities
The quick ratio has declined by 14% year-on-year and by 5% since the previous quarter
Accuray's current ratio has decreased by 13% YoY and by 4.8% QoQ
ARAY's equity is down by 8% YoY and by 6% QoQ
The company's debt to equity rose by 6% YoY and by 5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.